Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy

被引：159

作者：

Stilgenbauer, S ^{[1
]}

Döhner, H ^{[1
]}

机构：

[1] Univ Ulm, D-89081 Ulm, Germany

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 06期

关键词：

D O I：

10.1056/NEJM200208083470619

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：452 / 453

页数：2

共 5 条

[1] Genomic aberrations and survival in chronic lymphocytic leukemia. [J].

Döhner, H ;

Stilgenbauer, S ;

Benner, A ;

Leupolt, E ;

Kröber, A ;

Bullinger, L ;

Döhner, K ;

Bentz, M ;

Lichter, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916

[2] P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS [J].

DOHNER, H ;

FISCHER, K ;

BENTZ, M ;

HANSEN, K ;

BENNER, A ;

CABOT, G ;

DIEHL, D ;

SCHLENK, R ;

COY, J ;

STILGENBAUER, S ;

VOLKMANN, M ;

GALLE, PR ;

POUSTKA, A ;

HUNSTEIN, W ;

LICHTER, P .

BLOOD, 1995, 85 (06) :1580-1589

[3]

KEATING M, IN PRESS LEUK LYMPHO

[4] Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study [J].

Keating, MJ ;

Flinn, I ;

Jain, V ;

Binet, JL ;

Hillmen, P ;

Byrd, J ;

Albitar, M ;

Brettman, L ;

Santabarbara, P ;

Wacker, B ;

Rai, KR .

BLOOD, 2002, 99 (10) :3554-3561

[5] Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. [J].

Rai, KR ;

Peterson, BL ;

Appelbaum, FR ;

Kolitz, J ;

Elias, L ;

Shepherd, L ;

Hines, J ;

Threatte, GA ;

Larson, RA ;

Cheson, BD ;

Schiffer, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (24) :1750-1757

← 1 →